Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine  AACR Conference on Molecular Diagnostics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

Cancer Research 68, 3370-3378, May 1, 2008. doi: 10.1158/0008-5472.CAN-07-5831
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Agarwal, M.
Right arrow Articles by Pandita, T. K.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Agarwal, M.
Right arrow Articles by Pandita, T. K.

Experimental Therapeutics, Molecular Targets, and Chemical Biology

Inhibition of Telomerase Activity Enhances Hyperthermia-Mediated Radiosensitization

Manjula Agarwal1, Shruti Pandita1, Clayton R. Hunt1, Arun Gupta1, Xuan Yue2, Saira Khan1, Raj K. Pandita1, David Pratt1, Jerry W. Shay3, John-Stephen A. Taylor2 and Tej K. Pandita1

1 Department of Radiation Oncology, Washington University School of Medicine; 2 Department of Chemistry, Washington University, St. Louis, Missouri; and 3 Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas

Requests for reprints: Tej K. Pandita, Department of Radiation Oncology, Washington University School of Medicine, 4511 Forest Park, St. Louis, MO 63108. Phone: 314-747-5461; Fax: 314-362-9790; E-mail: pandita{at}wustl.edu.

Key Words: telomerase • heat shock • survival • ionizing radiation • hTR • antisense • LNA • PNA • GRN163L

Hyperthermia is a potent sensitizer of cell killing by ionizing radiation (IR); however, hyperthermia also induces heat shock protein 70 (HSP70) synthesis and HSP70 expression is associated with radioresistance. Because HSP70 interacts with the telomerase complex and expression of the telomerase catalytic unit (hTERT) extends the life span of the human cells, we determined if heat shock influences telomerase activity and whether telomerase inhibition enhances heat-mediated IR-induced cell killing. In the present study, we show that moderate hyperthermia (43°C) enhances telomerase activity. Inhibition of telomerase activity with human telomerase RNA–targeted antisense agents, and in particular GRN163L, results in enhanced hyperthermia-mediated IR-induced cell killing, and ectopic expression of catalytic unit of telomerase (TERT) decreased hyperthermia-mediated IR-induced cell killing. The increased cell killing by heat and IR exposure in telomerase-inhibited cells correlates with delayed appearance and disappearance of {gamma}-H2AX foci as well as decreased chromosome repair. These results suggest that inactivation of telomerase before combined hyperthermia and radiotherapy could improve tumor killing. [Cancer Res 2008;68(9):3370–9]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2008 by the American Association for Cancer Research.